Why an acquisition deal won’t save Walgreens’ future

This week, the retail industry has been buzzing over the news of pharmaceutical retailer Walgreens’ potential deal with private equity firm Sycamore Partners. 

An excitement which has led to shares of the second-largest US pharmacy chain operator surging over 18 per cent…